Here, we review data concerning the configuration of the IG genes in CLL and how studies of these genes have shed light on the pathogenesis and progression of CLL. In normal B cells, replacement ...

Chronic lymphocytic leukemia (CLL) is a cancer that affects ... CLL can get worse and become a more aggressive cancer called diffuse large B-cell lymphoma, also called Richter's syndrome or ...

Chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL) are types of blood cancer. They develop in types of white blood cells called B cells or T cells, or the precursors to these cells.

Chronic lymphocytic leukemia (CLL) is a type of cancer affecting ... and Imbruvica (ibrutinib), and antiapoptotic protein B ...

What Is B-Cell Acute Lymphoblastic Leukemia? B-cell acute lymphoblastic leukemia is a cancer that affects your "B lymphocytes" -- white blood cells that grow in the soft center of your bones ...

a disease which cannot be fully understood when considered just as simple B-cell monoclonal malignancy. The Surveillance E, and End Results (SEER) Program of the National Cancer Institute, Cancer Stat ...

Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL ...

This combination works by targeting cancerous B cells ... the cancer cells to die. When used together, these drugs can slow down or even stop the growth of the leukemia cells.

HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless of treatment employed, according ...

Lisocabtagene maraleucel significantly improved responses rates and survival outcomes among patients with relapsed or refractory chronic lymphocytic leukemia, according to findings presented at ASCO ...

Venetoclax is under clinical development by AbbVie and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...